Paradigm Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Paradigm Asset Management's BIIB Position: Q3 2026 in Review
Paradigm Asset Management sold out of Biogen (BIIB) in Q3 2026, closing a stake of 455 shares — an estimated $98.3K sold.
Paradigm Asset Management first reported a position in BIIB in Q4 2013 and held it in 25 quarters. The position peaked at $2.63M in Q2 2021. 1,052 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Paradigm Asset Management reported no remaining Biogen position as of Q3 2026 after selling out during the quarter.
- Paradigm Asset Management sold 455 Biogen shares in Q3 2026, an estimated $98.3K.
- Paradigm Asset Management first reported a position in Biogen in Q4 2013 and held it in 25 quarters.
- Paradigm Asset Management's Biogen position peaked at $2.63M in Q2 2021.
- 1,052 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Paradigm Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.